Philip-Joët F, Alessi M C, Philip-Joët C, Aillaud M, Barriere J R, Arnaud A, Juhan-Vague I
Service de Pneumologie-Allergologie, CHU Nord, Marseille, France.
Eur Respir J. 1995 Aug;8(8):1352-6. doi: 10.1183/09031936.95.08081352.
This study was designed to evaluate major fibrinolytic parameters in relation to parameters of inflammation associated with different kinds of pleural effusion. Sixty patients with pleural effusion were studied. The underlying aetiology was empyema in 10 cases, tuberculosis in 9, cancer in 31, cardiac failure in 7, and undetermined in 3. Plasminogen, plasminogen activator inhibitor 1 (PAI-1) and 2 (PAI-2), tissue type plasminogen activator (t-PA), urokinase (u-PA) and D-dimers (D-D) were quantified in plasma samples and pleural effusion specimens. These data were then correlated with inflammatory or infectious parameters, i.e. fibrinogen, von Willebrand factor (vWF), erythrocyte sedimentation rate (ESR), protein concentration, and white blood cell count. D-D levels were higher in pleural fluid than in plasma. D-D levels were not correlated with either plasminogen activator or plasminogen activator inhibitor levels, suggesting the presence of other fibrinolytic pathways. PAI levels (PAI activity, PAI-1 antigenicity, PAI-2 antigenicity) and vWF levels were significantly higher in patients with tuberculosis and empyema than in patients with cancer or cardiac failure. Regression analysis between inflammatory and fibrinolytic parameters showed that pleural PAI levels were significantly correlated with pleural neutrophil count, vWF levels, and plasma fibrinogen levels. D-D levels were correlated with blood ESR. No significant difference in pleural t-PA, u-PA and D-D levels was observed between aetiologies. The highest pleural t-PA and u-PA values were noted in patients with cancer, especially lymphoma. Plasma t-PA levels were higher inpatients with pleural effusion secondary to congestive heart failure, but this difference did not reach statistical significance.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究旨在评估与不同类型胸腔积液相关的炎症参数有关的主要纤溶参数。对60例胸腔积液患者进行了研究。潜在病因分别为:脓胸10例,结核9例,癌症31例,心力衰竭7例,病因不明3例。对血浆样本和胸腔积液标本中的纤溶酶原、纤溶酶原激活物抑制剂1(PAI - 1)和2(PAI - 2)、组织型纤溶酶原激活物(t - PA)、尿激酶(u - PA)和D - 二聚体(D - D)进行了定量分析。然后将这些数据与炎症或感染参数,即纤维蛋白原、血管性血友病因子(vWF)、红细胞沉降率(ESR)、蛋白浓度和白细胞计数进行关联分析。胸腔积液中的D - D水平高于血浆。D - D水平与纤溶酶原激活物或纤溶酶原激活物抑制剂水平均无相关性,提示存在其他纤溶途径。结核和脓胸患者的PAI水平(PAI活性、PAI - 1抗原性、PAI - 2抗原性)和vWF水平显著高于癌症或心力衰竭患者。炎症和纤溶参数之间的回归分析表明,胸腔PAI水平与胸腔中性粒细胞计数、vWF水平和血浆纤维蛋白原水平显著相关。D - D水平与血液ESR相关。不同病因之间胸腔t - PA、u - PA和D - D水平无显著差异。癌症患者,尤其是淋巴瘤患者的胸腔t - PA和u - PA值最高。充血性心力衰竭继发胸腔积液患者的血浆t - PA水平较高,但这一差异未达到统计学意义。(摘要截选至250词)